(Q39426343)
Statements
1 reference
Comparison of 0.5% intrathecal bupivacaine with 0.5% intrathecal ropivacaine in the treatment of refractory cancer and noncancer pain conditions: results from a prospective, crossover, double-blind, randomized study (English)
1 reference
Dahm P
1 reference
Lundborg C
1 reference
Janson M
1 reference
Olegård C
1 reference
Nitescu P
1 reference
1 September 2000
1 reference
1 reference
25
1 reference
5
1 reference
480-487
1 reference
Identifiers
1 reference
1 reference